GlassScriptPhysician profile
Muhammad Bilal
NPI 1417290057
$895.15
in general payments reported to CMS, 2019-2025
21 companies · $23.11 in 2025
The $23.11 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $590 · 2020: $81.27 · 2021: $157 · 2022: $17.23 · 2023: $12.98 · 2024: $13.48 · 2025: $23.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $49.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $49.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $178.06 | 2019-2021 | |
| Livanova USA, INC. | $172.81 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $125.00 | 2021 | |
| Ucb, INC. | $67.95 | 2019-2020 | |
| Mdd US Operations, LLC | $61.80 | 2019 | |
| Neurocrine Biosciences, INC. | $33.79 | 2019 | |
| Alexion Pharmaceuticals, INC. | $24.89 | 2019-2020 | |
| Genzyme Corporation | $24.12 | 2019 | |
| Pfizer INC. | $23.11 | 2025 | |
| Grifols USA, LLC | $18.96 | 2019 | |
| Upsher-Smith Laboratories LLC | $17.84 | 2020 | |
| Sunovion Pharmaceuticals INC. | $17.30 | 2019 | |
| Mallinckrodt Hospital Products INC. | $17.23 | 2022 | |
| Allergan, INC. | $16.92 | 2019 | |
| Supernus Pharmaceuticals, INC. | $16.56 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $14.62 | 2019 | |
| Portola Pharmaceuticals, LLC | $14.36 | 2019 | |
| Boston Scientific Corporation | $13.48 | 2024 | Watchman Access System |
| Puma Biotechnology, INC. | $12.98 | 2023 | Nerlynx |
| Acadia Pharmaceuticals INC | $12.14 | 2021 | |
| Lilly USA, LLC | $11.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Bilal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.